DC-355/B1

N/A

Report date: 2025/03/18 18:16:55
NME

Base Information

Drug NameDC-355/B1
Drug Alias NameRNAP inhibitor (Demuris)tuberculosis program (Demuris)
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsNatural product/Extract
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsMultidrug-Resistant InfectionTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDemuris Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDemuris Ltd
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A